Alimera Sciences Aktie (A2PVHE | ALIM

Was macht Alimera Sciences?

Unternehmensprofil

Alimera Sciences is a pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. The company is passionate about protecting the retina and developing innovative treatments to preserve vision.

Chart der Alimera Sciences Aktie

Charttool öffnen

Aktuelle Nachrichten zu Alimera Sciences

Weitere Nachrichten

Das berichten andere über Alimera Sciences

Alimera Sciences: Schnelle +25% für NBC-Anleger!

Im No Brainer Club (NBC) jagt mal wieder ein Erfolg den Nächsten. So konnten Mitglieder des Anlegerclubs mit Alimera Sciences ($ALIM) innerhalb von 2 Tagen +25% Gewinn einstreichen....

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today announced the completion of its previously...

ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences

PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (“ANI” or the “Company”) announced today that the Company has initiated...

Alimera Sciences Aktie